Siebert W T, Moreland N, Williams T W
J Infect Dis. 1979 Apr;139(4):452-7. doi: 10.1093/infdis/139.4.452.
The in vitro activity of cephalothin, cefazolin, and vancomycin against 25 isolates of methicillin-resistant Staphylococcus epidermidis was determined by means of a broth dilution technique with two sizes of inoculum. The size of the inoculum had a marked effect on the minimal inhibitory concentrations and the minimal bactericidal concentrations of all three antibiotics. With a small inoculum, 100% of the isolates were inhibited by 3.12 micrograms of vancomycin/ml, 76% by 12.5 micrograms of cephalothin/ml, and 64% by 12.5 micrograms of cefazolin/ml. With a large inoculum 100% of the isolates were inhibited by 200 micrograms of vancomycin/ml, 40% by 12.5 micrograms of cephalothin/ml, and 12% by 12.5 micrograms of cefazolin/ml. As determined by a tube dilution checkerboard technique for both sizes of inoculum, the combination of vancomycin plus cephalothin was synergistic against methicillin-resistant S. epidermidis in 45 of 50 cases, and the combination of vancomycin plus cefazolin was synergistic in 39 or 50 cases. These data from in vitro studies suggest that these antibiotic combinations should be evaluated clinically in patients with severe infections caused by methicillin-resistant S. epidermidis.
采用肉汤稀释技术,以两种接种量测定了头孢噻吩、头孢唑林和万古霉素对25株耐甲氧西林表皮葡萄球菌的体外活性。接种量大小对这三种抗生素的最低抑菌浓度和最低杀菌浓度有显著影响。接种量较小时,100%的菌株被3.12微克/毫升的万古霉素抑制,76%被12.5微克/毫升的头孢噻吩抑制,64%被12.5微克/毫升的头孢唑林抑制。接种量较大时,100%的菌株被200微克/毫升的万古霉素抑制,40%被12.5微克/毫升的头孢噻吩抑制,12%被12.5微克/毫升的头孢唑林抑制。通过试管稀释棋盘法对两种接种量进行测定,万古霉素加头孢噻吩的联合用药在50例中有45例对耐甲氧西林表皮葡萄球菌具有协同作用,万古霉素加头孢唑林的联合用药在50例中有39例具有协同作用。这些体外研究数据表明,对于由耐甲氧西林表皮葡萄球菌引起的严重感染患者,应在临床上对这些抗生素联合用药进行评估。